$53.06
+
$4.54 (8.56%)
End-of-day quote: 05/10/2024
NasdaqGS:INCY
Incyte Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $129.29 | $130.51 | 0.00% | 11 | $327.47B |
| ABBV | AbbVie | NYSE | Outperform | $161.28 | $178.42 | 0.00% | 11 | $284.80B |
| AZN | AstraZeneca PLC | LSE | Outperform | £123.18 | £165.99 | 0.00% | 16 | £190.96B |
| NOVN | Novartis | SWX | Hold | CHF93.07 | CHF105.00 | 0.00% | 9 | CHF189.90B |
| ROG | Roche Holding | SWX | Hold | CHF227.80 | CHF307.83 | 0.00% | 9 | CHF183.89B |
| AMGN | Amgen | NasdaqGS | Outperform | $308.45 | $303.65 | 0.00% | 8 | $165.46B |
| SAN | Sanofi | ENXTPA | Outperform | 92.71€ | 102.80€ | 0.00% | 9 | 115.76€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $976.96 | $961.26 | 0.00% | 8 | $105.40B |
| GSK | GSK | LSE | Outperform | £18.10 | £17.30 | 0.00% | 12 | £73.81B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $45.06 | $58.15 | 0.00% | 10 | $91.34B |
| MRK | Merck KGaA | XTRA | Outperform | 154.50€ | 190.06€ | 0.00% | 4 | 67.17€B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.10k | ¥4.74k | 0.00% | 0 | ¥6.44T |
| 4523 | Eisai | TSE | Outperform | ¥6.76k | ¥9.58k | 0.00% | 0 | ¥1.95T |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $113.17 | $188.32 | 0.00% | 4 | $7.13B |
| EXEL | Exelixis | NasdaqGS | Outperform | $21.27 | $26.44 | 0.00% | 5 | $6.34B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $38.80 | $55.60 | 0.00% | 3 | $5.76B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $43.01 | $79.81 | 0.00% | 3 | $5.16B |
| MOR | MorphoSys | XTRA | Hold | 67.35€ | 28.78€ | 0.00% | 3 | 2.52€B |
| GERN | Geron | NasdaqGS | Outperform | $3.74 | $4.83 | 0.00% | 1 | $2.30B |
| PGEN | Precigen | NasdaqGS | Outperform | $1.35 | $9.46 | 0.00% | 2 | $325.62M |
| OMER | Omeros | NasdaqGM | Hold | $3.75 | $13.00 | 0.00% | 2 | $204.54M |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $0.98 | $3.26 | 0.00% | 1 | $183.05M |
| KPTI | Karyopharm Therapeutics | NasdaqGS | Outperform | $1.12 | $6.00 | 0.00% | 1 | $118.80M |
| DXB | Dimerix | ASX | $0.33 | $0.00 | 0.00% | 0 | $159.38M | |
| BLRX | BioLineRx | TASE | - | ₪0.16 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.25 | $9.44 | 0.00% | 2 | $70.66M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.49 | $80.00 | 0.00% | 0 | $9.39M |
